BridgeBio to Present Long-Term Efficacy and Safety Data from the ATTRibute-CM OLE Trial at the ACC Annual Scientific Sessions

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. IBM
4. META
5. NAVN
6. DFTX
7. CNC
8. KFY
9. SPY
10. MU

Go back to BridgeBio to Present Long-Term Efficacy and Safety Data from the ATTRibute-CM OLE Trial at the ACC Annual Scientific Sessions
(NASDAQ: BBIO) Delayed: 68.92 --0 (-0%)
Previous Close $68.92    52 Week High $ 
Open $68.92    52 Week Low $ 
Day High $68.92    P/E N/A 
Day Low $68.92    EPS $ 
Volume 117